These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29243264)

  • 1. Prolonged platelet storage associated with increased frequency of transfusion-related adverse events.
    Losos M; Biller E; Li J; Blower L; Hamad D; Patel G; Scrape S; Cataland S; Chen J
    Vox Sang; 2018 Feb; 113(2):170-176. PubMed ID: 29243264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion reactions after transfusion of platelets stored in PAS-B, PAS-C, or plasma: a nationwide comparison.
    van Hout FMA; van der Meer PF; Wiersum-Osselton JC; Middelburg RA; Schipperus MR; van der Bom JG; Kerkhoffs JL
    Transfusion; 2018 Apr; 58(4):1021-1027. PubMed ID: 29405304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets.
    Charania R; Smith J; Vesely SK; Dale GL; Holter J
    Transfusion; 2011 Dec; 51(12):2690-4. PubMed ID: 21645004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion-related adverse events in the Platelet Dose study.
    Kaufman RM; Assmann SF; Triulzi DJ; Strauss RG; Ness P; Granger S; Slichter SJ
    Transfusion; 2015 Jan; 55(1):144-53. PubMed ID: 25065959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial.
    Snyder E; McCullough J; Slichter SJ; Strauss RG; Lopez-Plaza I; Lin JS; Corash L; Conlan MG;
    Transfusion; 2005 Dec; 45(12):1864-75. PubMed ID: 16371039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age of platelet concentrates and time to the next transfusion.
    Caram-Deelder C; van der Bom JG; Putter H; Leyte A; Kerkhof DV; Evers D; Beckers EA; Weerkamp F; Hudig F; Zwaginga JJ; Rondeel JMM; de Vooght KMK; Péquériaux NCV; Visser O; Wallis JP; Middelburg RA
    Transfusion; 2018 Jan; 58(1):121-131. PubMed ID: 29090466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine use of Day 6 and Day 7 platelets with rapid testing: two hospitals assess impact 1 year after implementation.
    Harm SK; Szczepiorkowski ZM; Dunbar NM
    Transfusion; 2018 Apr; 58(4):938-942. PubMed ID: 29332317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viability and function of 8-day-stored apheresis platelets.
    Slichter SJ; Bolgiano D; Jones MK; Christoffel T; Corson J; Rose L; Foley J; Popovsky M; Baril LL; Corda T; Dincecco DM; Snyder EL
    Transfusion; 2006 Oct; 46(10):1763-9. PubMed ID: 17002633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of simulated shipping conditions (24- or 30-hr interruption of agitation) on the in vitro properties of apheresis platelets during 7-day storage.
    Wagner SJ; Vassallo R; Skripchenko A; Einarson M; Seetharaman S; Moroff G
    Transfusion; 2008 Jun; 48(6):1072-80. PubMed ID: 18373503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of gamma irradiation on the quality of apheresis platelets during storage for 7 days.
    Tynngård N; Studer M; Lindahl TL; Trinks M; Berlin G
    Transfusion; 2008 Aug; 48(8):1669-75. PubMed ID: 18482187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet components associated with adverse reactions: predictive value of mitochondrial DNA relative to biological response modifiers.
    Cognasse F; Aloui C; Anh Nguyen K; Hamzeh-Cognasse H; Fagan J; Arthaud CA; Eyraud MA; Sebban M; Fromont E; Pozzetto B; Laradi S; Garraud O
    Transfusion; 2016 Feb; 56(2):497-504. PubMed ID: 26446055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA class I depletion by citric acid, and irradiation of apheresis platelets for transfusion of refractory patients.
    Mirlashari MR; Vetlesen A; Nissen-Meyer LSH; Naper C; Tjønnfjord GE; Njerve IU; Ezligini F; Landmark BF; Meinke S; Sandgren P; Höglund P; Hetland G
    Transfusion; 2021 Apr; 61(4):1222-1234. PubMed ID: 33580979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apheresis technology correlates with bacterial contamination of platelets and reported septic transfusion reactions.
    Eder AF; Dy BA; DeMerse B; Wagner SJ; Stramer SL; O'Neill EM; Herron RM
    Transfusion; 2017 Dec; 57(12):2969-2976. PubMed ID: 28880363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparison of Transfusion-Related Adverse Reactions Among Apheresis Platelets, Whole Blood-Derived Platelets, and Platelets Subjected to Pathogen Reduction Technology as Reported to the National Healthcare Safety Network Hemovigilance Module.
    Mowla SJ; Kracalik IT; Sapiano MRP; O'Hearn L; Andrzejewski C; Basavaraju SV
    Transfus Med Rev; 2021 Apr; 35(2):78-84. PubMed ID: 33934903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
    Skripchenko A; Kurtz J; Moroff G; Wagner SJ
    Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial.
    Enright H; Davis K; Gernsheimer T; McCullough JJ; Woodson R; Slichter SJ
    Transfusion; 2003 Nov; 43(11):1545-52. PubMed ID: 14617313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rest period before agitation may improve some in vitro apheresis platelet parameters during storage.
    Skripchenko A; Myrup A; Awatefe H; Thompson-Montgomery D; Wagner SJ
    Transfusion; 2012 Jul; 52(7):1433-8. PubMed ID: 22211457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic analysis of platelets during storage: a comparison between apheresis- and buffy coat-derived platelet concentrates.
    Paglia G; Sigurjónsson ÓE; Rolfsson Ó; Hansen MB; Brynjólfsson S; Gudmundsson S; Palsson BO
    Transfusion; 2015 Feb; 55(2):301-13. PubMed ID: 25156572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing the risk of bacterial contamination in platelets: a hospital economic perspective.
    Li JW; Brecher ME; Jacobson JL; Harm SK; Chen D; El-Gamil A; Dobson A; Mintz PD
    Transfusion; 2017 Oct; 57(10):2321-2328. PubMed ID: 28703862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the efficacy and safety of apheresis and whole blood-derived platelet transfusions: a systematic review.
    Heddle NM; Arnold DM; Boye D; Webert KE; Resz I; Dumont LJ
    Transfusion; 2008 Jul; 48(7):1447-58. PubMed ID: 18482183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.